Late Toxicities after Left-Sided Breast Cancer Radiotherapy in Women: Impact of Modern External Beam Radiotherapy Techniques
Author : Hamigah Anton Tharshanth
Abstract :
Radiotherapy is an important treatment method for breast cancer; though, women with left-sided breast cancer may at risk of late radiation-related toxicity because of the closeness of the heart, coronary arteries, and ipsilateral lung to the treatment volume. With increasing long-term survival, minimizing treatment-related morbidity while maintaining adequate target coverage has become an important objective of modern radiotherapy. This review focuses the major late toxicities related with radiotherapy for left-sided breast cancer in women and critically examines the impact of modern external beam radiotherapy techniques on normal-tissue exposure and possible late toxicity. A structured literature search was conducted addressing late toxicities and modern radiotherapy approaches in adult women with left-sided breast cancer. Evidence was critically assessed according to study design, sample size, follow-up duration, toxicity assessment, dosimetric parameters, and late effects. Cardiac and pulmonary toxicities remain important late complications following left-sided breast irradiation. Modern techniques, including three-dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT), volumetric-modulated arc therapy (VMAT), deep inspiration breath-hold (DIBH), image-guided radiotherapy (IGRT), surface-guided respiratory management, and proton therapy, provide increasingly effective opportunities to reduce radiation exposure to organs at risk while maintaining target coverage. DIBH lead reductions in mean heart dose (MHD) and may also reduce irradiation of the left anterior descending (LAD) coronary artery. IMRT and VMAT improve dose conformity but may increase low-dose exposure to surrounding normal tissues. Proton therapy can provide substantial dosimetric advantages in selected patients, although its long-term clinical benefit remains less well established. Modern radiotherapy techniques significantly improved the normal-tissue sparing in women with left-sided breast cancer. Longer-term studies, standardized toxicity assessment, cardiac dose-response evaluation, and patient-specific risk evaluations are required to determine the clinical significance of these technological advances.
Keywords :
Left-sided breast cancer; radiotherapy; late toxicity; cardiac toxicity; DIBH.